Cancer Drug Parity Act of 2025

This bill would make employer group health plans treat cancer pills the same as chemo given in a clinic when it comes to what patients pay out of pocket. It requires plans to offer cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing for anticancer medicines given by a health care provider.

Key points:

• Who is affected: People enrolled in group health plans (and the plans themselves).
• What changes: Out-of-pocket costs for cancer pills must be no worse than for provider-administered cancer drugs.
• Where it fits: It amends federal rules for employer health plans to ensure this parity.